ITM ernennt Dr. Andrew Cavey zum CEO, um das weitere Wachstum des Unternehmens voranzutreiben
June 20, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Dr. Cavey verfügt über langjährige Berufserfahrung in der radiopharmazeutischen Industrie und wird die Weiterentwicklung von ITMs Pipeline und das Unternehmenswachstum maßgeblich unterstützen....
ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth
June 20, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
With a significant track record of success in the radiopharmaceutical industry, Dr. Cavey will help accelerate ITM’s pipeline and business growth Garching /...
ITM Appoints Dr. Mark Harfensteller as Member of its Executive Board
January 16, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Dr. Mark Harfensteller to its...